Literature DB >> 5579464

Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver.

K D Kolenda, H Lüllmann, T Peters.   

Abstract

1. Metabolic degradation of tritiated ouabain, digoxin, and digitoxin has been investigated quantitatively using the isolated perfused guinea-pig liver. The cardiac glycosides and their metabolites have been extracted from the plasma, liver, and bile by different solvents and identified as far as possible by radio-chromatographic analysis.2. The total metabolic activity in the experimental system was localized in the liver.3. The hydrophilic glycoside ouabain could not penetrate into the metabolically active compartment of the liver and was, therefore, not degraded. The more lipophilic compound digitoxin, however, was completely degraded due to its high affinity for the metabolically active sites. The unchanged digitoxin cannot enter the aqueous bile fluid in contrast to its more hydrophilic metabolites.4. The only detectable metabolic degradation of digoxin was a conjugation with glucuronic and/or sulphuric acid, but a cleavage of sugar molecules seemed not to occur.5. In the case of digitoxin the metabolic processes are more complicated: sugar cleavage, conjugation, and C-12 hydroxylation take place simultaneously. An immediate hydroxylation of digitoxin leading to digoxin was not observed. After administration of digitoxin conjugation products as well as digoxigenin-bis-and digoxigenin-mono-digitoxosides were present in each of the compartments investigated, but the digitoxosides of digitoxigenin were intermediates in concentrations too low to be determined indicating a very high rate of conjugation and/or C-12 hydroxylation as compared with the cleavage of the digitoxoses.6. A scheme for the metabolic pathways of the cardiac glycosides based on experimental results is presented. The metabolic behaviour of each of the three compounds involved is closely related to their physicochemical properties, especially the lipid solubility.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5579464      PMCID: PMC1702767          DOI: 10.1111/j.1476-5381.1971.tb07074.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Metabolism of cardiac glycosides. I. Metabolism of digitoxin-7-alpha-T by normal rabbits and rabbits with heart failure.

Authors:  C L Griffin; S H Burstein
Journal:  Biochem Pharmacol       Date:  1967-03       Impact factor: 5.858

2.  [Biochemistry and clinical aspects of digitalis].

Authors:  K Repke
Journal:  Internist (Berl)       Date:  1966-08       Impact factor: 0.743

3.  Species and sex variation in the hepatic metabolism of H3-digoxin in vitro.

Authors:  G L Lage; J L Spratt
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

4.  H3-digoxin metabolism by adult male rat tissues in vitro.

Authors:  G L Lage; J L Spratt
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

5.  Excretion of radioactive digitoxin by the dog.

Authors:  B G Katzung; F H Meyers
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

6.  Metabolism of digoxin: role of the liver in tritiated digoxin degradation.

Authors:  R J Abel RM LUCHI; G W Peskin; H L Conn; L D Miller
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

7.  The uptake and content of digitoxin and its metabolites in the heart muscle of rats and guinea-pigs after acute and chronic application.

Authors:  W Förster; K Grade
Journal:  Biochem Pharmacol       Date:  1967-07-07       Impact factor: 5.858

8.  [Determination of protein binding of digitalis preparations by means of the ultracentrifuge].

Authors:  W Scholtan; K Schlossmann; H Rosenkranz
Journal:  Arzneimittelforschung       Date:  1966-02

9.  Biotransformation of digitoxin in the dog.

Authors:  B G Katzung; F H Meyers
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

10.  Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors:  F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690

View more
  8 in total

1.  Molecular interactions with redox sites and salt bridges modulate the anti-aggregatory effect of flavonoid, tannin and cardenolide moieties against amyloid-beta (1-42) in silico.

Authors:  Rafael Vincent M Manalo
Journal:  In Silico Pharmacol       Date:  2017-10-13

2.  The uptake and subcellular distribution of radio-labeled metabolites of digoxin in the isolated perfused guinea-pig heart.

Authors:  P M Stephen; S Dutta; B H Marks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  Metabolism of digoxigenin, digoxigeninmonodigitoxoside and digoxigeninbisdigitoxoside in rats.

Authors:  U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Quantitative analysis of digoxin, 4'''-acetyldigoxin and 4'''-methyldigoxin and their metabolites in bile and urine of rats.

Authors:  K von Bergmann; U Abshagen; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  A simple approach to follow the metabolic degradation of cardiac glycosides in vivo.

Authors:  A Glover; F Kokenge; H Lüllmann; T Peters; K U Seiler; P A van Zweiten
Journal:  Klin Wochenschr       Date:  1971-10-01

6.  [A comparative study of the action of digoxigenin-mono, bis- and tridigitoxosides in the cat heart-lung preparation (author's transl)].

Authors:  H Böttcher; K Fischer; D Proppe
Journal:  Basic Res Cardiol       Date:  1975 May-Jun       Impact factor: 17.165

7.  Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea-pig liver.

Authors:  K D Kolenda; H Lüllmann; T Peters; K U Seiler
Journal:  Br J Pharmacol       Date:  1971-04       Impact factor: 8.739

8.  Formation and disposition of bis- and monoglycosides after administration of 3H-4'''-methyldigoxin to man.

Authors:  U Abshagen; H Rennekamp; R Küchler; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.